The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,868.00
Bid: 1,856.00
Ask: 1,864.00
Change: -30.00 (-1.58%)
Spread: 8.00 (0.431%)
Open: 1,868.00
High: 1,894.00
Low: 1,848.00
Prev. Close: 1,898.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ruthin Site Visit

3 Nov 2022 07:00

RNS Number : 1089F
Genus PLC
03 November 2022
 

3 November 2022

Genus plc

 

Ruthin Site Visit

 

Genus plc (LSE: GNS), a leading global animal genetics company, is today hosting a site visit for sell side analysts and institutional investors to its production site in Ruthin, North Wales. The visit will showcase Genus's world class beef and dairy bulls, as well as its industry leading Intelligen technology.

No new information regarding current trading will be disclosed during the site visit.

Enquiries:

Genus plc

Stephen Wilson, Chief Executive Officer

Alison Henriksen, Chief Financial Officer

Tel: 01256 345970

Buchanan

Charles Ryland / Chris Lane / Verity Parker

Tel: 0207 466 5000

 

About Genus

Genus advances animal breeding and genetic improvement by applying biotechnology and sells added value products for livestock farming and food producers. Its technology is applicable across livestock species and is currently commercialised by Genus in the dairy, beef and pork food production sectors.

Genus's worldwide sales are made in over 75 countries under the trademarks 'ABS' (dairy and beef cattle) and 'PIC' (pigs) and comprise semen, embryos and breeding animals with superior genetics to those animals currently in farms. Genus's customers' animals produce offspring with greater production efficiency and quality, and our customers use them to supply the global dairy and meat supply chains.

Genus's competitive edge comes from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global supply chain, technical service and sales and distribution network.

Headquartered in Basingstoke, United Kingdom, Genus companies operate in over 24 countries on six continents, with research laboratories located in Madison, Wisconsin, USA.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKBBDNBDDADK
Date   Source Headline
27th Oct 20112:00 pmRNSAnnual Information Update
11th Oct 201111:39 amRNSAnnual Report and Annual General Meeting
30th Sep 20112:44 pmRNSTotal Voting Rights
22nd Sep 20112:33 pmRNSHolding(s) in Company
20th Sep 20113:08 pmRNSAdditional Listing
20th Sep 20113:07 pmRNSDirector/PDMR Shareholding
9th Sep 201111:00 amRNSDirector/PDMR Shareholding
6th Sep 20117:00 amRNSPreliminary Results
31st Aug 20112:00 pmRNSTotal Voting Rights
29th Jul 20112:00 pmRNSBlocklisting Interim Review
29th Jul 20112:00 pmRNSTotal Voting Rights
4th Jul 20117:00 amRNSPre-close Trading Statement
25th May 20117:00 amRNSCEO Retirement and Appointment of Successor
12th May 20112:08 pmRNSHolding(s) in Company
11th May 20117:00 amRNSInterim Management Statement
28th Apr 20112:00 pmRNSTotal Voting Rights
31st Mar 20112:00 pmRNSTotal Voting Rights
10th Mar 20115:56 pmRNSHolding(s) in Company
9th Mar 201111:00 amRNSDirector Shareholding
28th Feb 20112:37 pmRNSTotal Voting Rights
22nd Feb 20117:00 amRNSInterim Results
31st Jan 20112:00 pmRNSBlocklisting Interim Review
31st Jan 20112:00 pmRNSTotal Voting Rights
27th Jan 20113:57 pmRNSNotice of Results
21st Jan 20113:36 pmRNSHolding(s) in Company
30th Nov 20102:00 pmRNSTotal Voting Rights
26th Nov 20104:27 pmRNSHolding(s) in Company
11th Nov 20103:33 pmRNSResult of AGM
11th Nov 20107:00 amRNSAGM and IMS
29th Oct 20102:30 pmRNSTotal Voting Rights
28th Oct 20107:00 amRNSStrategic Progress in India
27th Oct 20102:30 pmRNSAnnual Information Update
14th Oct 201010:00 amRNSAnnual Financial Report and AGM Meeting
30th Sep 20103:30 pmRNSTotal Voting Rights
27th Sep 20102:30 pmRNSDirector/PDMR Shareholding
22nd Sep 20103:16 pmRNSAdditional Listing
22nd Sep 20102:49 pmRNSDirector/PDMR Shareholding
15th Sep 20102:50 pmRNSDirector/PDMR Shareholding
13th Sep 201011:00 amRNSDirector/PDMR Shareholding
10th Sep 20102:00 pmRNSDirector/PDMR Shareholding
7th Sep 20107:01 amRNSBoard Change
7th Sep 20107:00 amRNSPreliminary Results
30th Jul 20102:00 pmRNSBlocklisting Interim Review
5th Jul 20107:00 amRNSPre-Close Trading Statement
17th Jun 20102:30 pmRNSHolding(s) in Company
3rd Jun 20103:30 pmRNSDirector's Shareholding
12th May 20107:00 amRNSInterim Management Statement
30th Apr 20102:00 pmRNSTotal Voting Rights
19th Apr 20102:58 pmRNSHolding(s) in Company
7th Apr 20102:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.